These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1093675)

  • 41. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 42. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
    Weber JS; Rosenberg SA
    Cancer Res; 1988 Oct; 48(20):5818-24. PubMed ID: 3139284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
    Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibody recognizing a human neuroblastoma-associated antigen.
    Smith RG; Reynolds CP
    Diagn Clin Immunol; 1987; 5(4):209-20. PubMed ID: 3322607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G; Ophir R; Pecht M; Ben-Efraim S
    In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetics of natural antitumor antibody production: antibodies to MHC-linked determinants detected in the serum of unstimulated mice.
    Wolosin LB; Greenberg AH
    J Immunol; 1981 Apr; 126(4):1456-9. PubMed ID: 6162890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity.
    Frikke MJ; Bridges SH; Lynch RG
    J Immunol; 1977 Jun; 118(6):2206-12. PubMed ID: 864258
    [No Abstract]   [Full Text] [Related]  

  • 51. Degradation of cell-bound antibodies by tumor cells from C57BL/6 mice.
    Keisari Y; Witz IP
    J Natl Cancer Inst; 1978 Oct; 61(4):1135-41. PubMed ID: 279714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onco-neural antigen: a new neural differentiation antigen expressed by neuroblastoma, oat cell carcinoma, Wilms' tumor, and sarcoma cells.
    Seeger RC; Zeltzer PM; Rayner SA
    J Immunol; 1979 Apr; 122(4):1548-55. PubMed ID: 221577
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibody formation and transient immune complex glomerulopathy in A-strain mice with C1300 neuroblastoma tumors.
    Faraggiana T; Biasio L; Marinozzi V; Butler R; Bertolini L; Revoltella R
    Virchows Arch B Cell Pathol; 1978 Mar; 27(1):23-38. PubMed ID: 148155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigens shared by rat schwannomas, neuroblastomas, and a testicular interstitial cell carcinoma.
    Harwood SE; Bigner DD; Wechsler W; Day ED
    Cancer Res; 1977 Sep; 37(9):3379-84. PubMed ID: 69493
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune responses to mouse neuroblastoma C1300. II. Cell-mediated kinetics and specificity studies.
    Della Penta D; Cipuzak PM; Phillips ME
    Int Arch Allergy Appl Immunol; 1982; 69(4):322-9. PubMed ID: 7141715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. X chromosome-linked defect of CBA/HN mice in production of tumor-reactive naturally occurring IgM antibodies.
    Martin SE; Martin WJ
    J Immunol; 1975 Aug; 115(2):502-7. PubMed ID: 168260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of alternating magnetic field (12 gauss) on transplanted neuroblastoma.
    Batkin S; Tabrah FL
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):351-62. PubMed ID: 847289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor localization of 131-I-labeled antibodies by radionuclide inaging.
    Ghose T; Tal J; Aquino J; Guclu A; Norvell S; MacDonald A
    Radiology; 1975 Aug; 116(02):445-8. PubMed ID: 1153748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A microradioimmunoassay for antibodies to tumor-associated antigens.
    Huang JC; Berczi I; Froese G; Tsay HM; Sehon AH
    J Natl Cancer Inst; 1975 Oct; 55(4):879-86. PubMed ID: 1102722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating immune complexes in murine neuroblastoma: quantification and shifts in immunoglobulin composition.
    Willems J; Joniau M
    Immunol Lett; 1983 Feb; 6(2):109-13. PubMed ID: 6852876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.